Indexing
All Issues
Submission
Author Guidelines
Reviewers
Editorial Members
Publication Fee
Vol.1 , No. 4, Publication Date: Oct. 27, 2014, Page: 113-118
 male and 17 (11.3%) females. Among the donors tested, 14(9.3%) were positive for hepatitis B while 136 (90.2%) were negative. The prevalence of hepatitis B was compared based on the gender and ABO blood group of blood donors. HBV infection was significantly higher among blood group O donors 8 (57.2%) compared to 3 (25.4 %), 2 (14.3%) and 1 (7.1%) respectively for group A, B and AB donors (p=0.01). The prevalence of hepatitis B was compared based on the age groups and type of blood donors. Hepatitis B prevalence was significantly higher among blood group O donors 8 (57.2%) compared to 3 (25.4 %), 2 (14.3%) and 1 (7.1%) respectively for group A, B and AB donors (p=0.01). The prevalence was highest among younger donors in the 18-28 years age group 10 (71.43%) compared to 3 (21.43%) and 1 (7.14%) respectively in the 29-38 and 39-48 years age groups. No infection was observed among older blood donors in the 49-58 and 59-68 years age groups (p=0.01). Married donors was significantly as risk for HBV 11(78.6%) compared to single 11(78.6%) blood donors (p=0.001). Hepatitis B prevalence was significantly higher among civil servants 6(42.9%) and farmers 4(28.6%) and lowest among traders and students 2(14.3%) (p=0.01). Hepatitis B infection was significantly higher among family replacement donors 13(92.9%) compared to voluntary non-remunerated blood donors 1(7.14%) (p=0.001). Blood donors should be routinely and mandatorily screened for hepatitis B to minimize the risk of transmission of HBV infection to the recipient. Effort should be made to recruit and retain voluntary non remunerated donors rather than high risk commercial and family replacement donors. There is need for public awareness, complete immunization against viral hepatitis B, better sanitation facilities, safe drinking water, increased availability of health care facilities for early detection and well equipped hospitals for intensive care.&picture=http://www.aascit.org/aascit/decorators/img/journal/908.jpg)
| [1] | Okwesili Augustine, Department of Haematology and Transfusion Medicine, Faculty of Medical Laboratory Science Usmanu Danfodiyo University, Sokoto, Nigeria. |
| [2] | Usman Ismail, Department of Haematology and Transfusion Medicine, Faculty of Medical Laboratory Science Usmanu Danfodiyo University, Sokoto, Nigeria. |
| [3] | Abubakar Wase, Department of Haematology and Transfusion Medicine, Faculty of Medical Laboratory Science Usmanu Danfodiyo University, Sokoto, Nigeria. |
| [4] | Onuigue Festus, Department of Haematology and Transfusion Medicine, Faculty of Medical Laboratory Science Usmanu Danfodiyo University, Sokoto, Nigeria. |
| [5] | Erhabor Osaro, Department of Haematology and Transfusion Medicine, Faculty of Medical Laboratory Science Usmanu Danfodiyo University, Sokoto, Nigeria. |
| [6] | Buhari Hauwa, Department of Haematology and Transfusion Medicine, Faculty of Medical Laboratory Science Usmanu Danfodiyo University, Sokoto, Nigeria. |
| [7] | Abdulrahaman Yakubu, Department of Clinical Chemistry, Faculty of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria. |
| [8] | Isaac Zama, Department of Haematology and Transfusion Medicine, Faculty of Medical Laboratory Science Usmanu Danfodiyo University, Sokoto, Nigeria. |
| [9] | Mainasara Yeldu, Department of Haematology and Transfusion Medicine, Faculty of Medical Laboratory Science Usmanu Danfodiyo University, Sokoto, Nigeria. |
| [10] | Aghedo Festus, Department of Haematology and Blood Transfusion, Usmanu Danfodio University Teaching Hospital, Sokoto, Nigeria. |
| [11] | Ikhuenbor Dorcas, Department of Haematology and Blood Transfusion, Usmanu Danfodio University Teaching Hospital, Sokoto, Nigeria. |
| [12] | Mohammed Haruna Yeldu, Department of Clinical Chemistry, Faculty of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria. |
| [13] | Dallatu Kabiru, Department of Clinical Chemistry, Faculty of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria. |
| [14] | Mainasara Abdulla, Department of Clinical Chemistry, Faculty of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria. |
| [15] | Gwarzo Sani, Department of Medical Laboratory Science, Bayero University Kano, Nigeria. |
Blood transfusion remains a substantial source of Hepatitis B Virus infection in sub Saharan Africa. In this present study we investigated the prevalence of hepatitis B infection among 150 consecutively- recruited blood donors aged 18 to 65 years and mean age 27.4 ± 6.6 made up of 133 (86.7%) male and 17 (11.3%) females. Among the donors tested, 14(9.3%) were positive for hepatitis B while 136 (90.2%) were negative. The prevalence of hepatitis B was compared based on the gender and ABO blood group of blood donors. HBV infection was significantly higher among blood group O donors 8 (57.2%) compared to 3 (25.4 %), 2 (14.3%) and 1 (7.1%) respectively for group A, B and AB donors (p=0.01). The prevalence of hepatitis B was compared based on the age groups and type of blood donors. Hepatitis B prevalence was significantly higher among blood group O donors 8 (57.2%) compared to 3 (25.4 %), 2 (14.3%) and 1 (7.1%) respectively for group A, B and AB donors (p=0.01). The prevalence was highest among younger donors in the 18-28 years age group 10 (71.43%) compared to 3 (21.43%) and 1 (7.14%) respectively in the 29-38 and 39-48 years age groups. No infection was observed among older blood donors in the 49-58 and 59-68 years age groups (p=0.01). Married donors was significantly as risk for HBV 11(78.6%) compared to single 11(78.6%) blood donors (p=0.001). Hepatitis B prevalence was significantly higher among civil servants 6(42.9%) and farmers 4(28.6%) and lowest among traders and students 2(14.3%) (p=0.01). Hepatitis B infection was significantly higher among family replacement donors 13(92.9%) compared to voluntary non-remunerated blood donors 1(7.14%) (p=0.001). Blood donors should be routinely and mandatorily screened for hepatitis B to minimize the risk of transmission of HBV infection to the recipient. Effort should be made to recruit and retain voluntary non remunerated donors rather than high risk commercial and family replacement donors. There is need for public awareness, complete immunization against viral hepatitis B, better sanitation facilities, safe drinking water, increased availability of health care facilities for early detection and well equipped hospitals for intensive care.
Keywords
Risk, Transfusion –Transmissible, Hepatitis B, Blood Donors, Sokoto, Nigeria
Reference
| [01] | Apata IW, Averhoff F, Pitman J, Bjork A, Yu J, Amin NA, Dhingra N, Kolwaite A, Marfin A; EIS officer, CDC. Progress towards prevention of transfusion-transmitted Hepatitis B and Hepatitis C infection - Sub-Saharan Africa, 2000-2011. MMWR Morb Mortal Wkly Rep. 2014; 63(29):613-619. |
| [02] | Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010; 14:1–21. |
| [03] | Datta S, Roychoudhury S, Ghosh A, Dasgupta D, Ghosh A, Chakraborty B, Roy S, Gupta S, Santra AK, Datta S, Das K, Dhali GK, Chowdhury A, Banerjee S. Distinct distribution pattern of hepatitis B virus genotype C and d in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patients. PLoS One. 2014;9(7):e102573. |
| [04] | Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, et al. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 2005; 54: 1162–1168. |
| [05] | World Health Organization. Hepatitis B. WHO Geneva. 2009. |
| [06] | Williams, R. Global challenges in liver disease. Hepatology 2006; 44(3): 521-526. |
| [07] | Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res. 2007; 37(1):S9-S19. |
| [08] | Olokoba AB, Salawu FK, Danburam A, Desalu OO, Olokoba LB, Wahab KW, Badung LH, Tidi SK, Midala J, Aderibigbe S, Abdulrahman MB, Babalola OM, Abdukkarim A. Viral Hepatitis in Voluntary Blood Donors in Yola, Nigeria. Euro. J. Scientific Res 2009; 31 (3): 329-334. |
| [09] | Ndako JA, Nwankiti OO, Echeonwu GON, Junaid SA, Anaele O, Anthony TJ. Studies on Prevalence and Risk Factors for Hepatitis B Surface Antigen among Secondary School Students in North-central, Nigeria. Sierra Leone J. Biomedical Res 2011; 3 (3): 163-168. |
| [10] | Ugwuja EI, Ugwu NC. Seroprevalence of Hepatitis B Surface Antigen and Liver Function Tests among Adolescents in Abakaliki, South Eastern Nigeria. The Internet J. Trop. Med 2010; 6 (2): 1-6. |
| [11] | National Population Commission (NPC). National Census Figures, Abuja, Nigeria. 2007. |
| [12] | Alikor EA, Erhabor O. Seroprevalence of hepatitis B surface antigenaemia in children in a tertiary health institution in the Niger Delta of Nigeria. Niger J Med. 2007; 16(4):326-329. |
| [13] | Dongdem TJ, Kampo S, Soyiri NI, Asebga PN, Ziem BJ, Sagoe K. Prevalence of hepatitis B virus infection among blood donors at the Tamale Teaching Hospital, Ghana. BMC Res Notes. 2012; 5:115. |
| [14] | Mustapha SK, Jibrin YB. The prevalence of hepatitis B surface antigenaemia in patients with human immunodeficiency virus (HIV) infection in Gombe, Nigeria. Ann Afr Med 2004; 3:10–12. |
| [15] | Sellati M P, Inwoley, A claix Ml et al. Prevalence of Hepatitis B/C virus and HCV genotypes in HIV positive and negative women in Abidjan, Ivory Coast West Africa 2003; 8 (1): 974. |
| [16] | Abdalla F, Mwanda FO, Rana W. Comparing Walk in and call-response donors in a national and a private hospital in Nairobi. East African Medical Journal 2005; 82(10): 531-535. |
| [17] | Glynn SA, Kleinman SH, Schreiber Trends in incidence and prevalence of major transfusion transmissible viral infection in the United States. J Am Med Assoc. 2000; 284:229–235. |
| [18] | Baba, M.M., Hassan, A.W., Gashau, W. Prevalence of hepatitis B antigenaemia and human immunodeficiency virus in blood donors in Maiduguri, Nigeria. Nigerian Journal of Medicine 2000; 9: 10-12. |
| [19] | Ampofo, W., Nil-Trebi, N., Ansah, J. Prevalence of blood-borne infectious diseases in blood donors in Ghana. Journal of Clinical Microbiology 2002; 40: 3523-3525. |
| [20] | Buseri FI, Muhibi MA, Jeremiah ZA. Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. Blood Transfus. 2009; 7(4):293-9. |
| [21] | Chikwem JO, Mohammed I, Okara GC. Prevalence of transmissible-blood infections among blood donors at the University of Maiduguri Teaching Hospital, Maiduguri, Nigeria. East African Medical Journal 1997; 4: 213-216. |
| [22] | Ejele OA, Erhabor O, Nwauche CA. Trends in the prevalence of some transfusion transmissible infections among the blood donors in Port-Harcourt Nigeria. Haema 2005; 8:273-277. |
| [23] | Egah DZ, Mandong BM, Iya D. Hepatitis C virus antibodies among blood donors in Jos, Nigeria. Annals of African Medicine 2004; 3: 35-37. |
| [24] | Bhatti FA. Anti-hepatitis B core antigen testing, viral markers and occult hepatitis B virus infection in Pakistani blood donors: implication for transfusion practice. Transfusion 2007; 47(1):74-79. |
| [25] | Abdalla F, Mwanda FO, Rana W. Comparing Walk in and call-response donors in a national and a private hospital in Nairobi. East African Medical Journal 2005; 82(10): 531-535. |
| [26] | Alavian SM, Fallahian F. Epidemiology of Hepatitis C in Iran and the world. Shiraz E- Medical Journal 2009; 10(4): 162-172. |
| [27] | Zuckerman A. In: Medical Microbiology. 4. Baron S, editor. Galveston: The University of Texas Branch at Galveston. Hepatitis Viruses. 1996: 849–863. |
| [28] | Kabinda JM, Miyanga SA, Misingi P, Ramazani SY. Hepatitis B and C among volunteer non-remunerated blood donors in Eastern Democratic Republic of Congo. Transfus Clin Biol. 2014; 21(3):111-5. |
| [29] | Batina A, Kabemba S, Malengela R.Infectious markers among blood donors in Democratic Republic of Congo (DRC). Rev Med Brux. 2007; 28(3):145-149. |
| [30] | Arora D, Arora B, Khetarpal A. Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana. Indian J Pathol Microbiol. 2010; 53(2):308-309. |
| [31] | Rerambiah LK, Rerambiah LE, Bengone C, Djoba Siawaya JF.The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. Blood Transfus. 2013; 3:1-4. |
| [32] | Mavenyengwa RT, Mukesi M, Chipare I, Shoombe E. Prevalence of human immunodeficiency virus, syphilis, hepatitis B and C in blood donations in Namibia. BMC Public Health. 2014; 14:424. |
| [33] | Mese S, Nergiz S, Tekes S, Gul K. Seroprevalence of serum HBsAg positivity and hepatitis delta virus infection among blood donors in Southeastern Turkey. Clin Ter. 2014; 165(2):95-98. |
| [34] | Flichman DM, Blejer JL, Livellara BI, Re VE, Bartoli S, Bustos JA, Ansola CP, Hidalgo S, Cerda ME, Levin AE, Huenul A, Riboldi V, Treviño EM, Salamone HJ, Nuñez FA, Fernández RJ, Reybaud JF, Campos RH. Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors. BMC Infect Dis. 2014; 14:218. |
| [35] | Yan Song, Ying Bian, Max Petzold, Carolina Oi Lam Ung.Prevalence and Trend of Major Transfusion-Transmissible Infections among Blood Donors in Western China, 2005 through 2010. PLoS One. 2014; 9(4): e94528. |
| [36] | Kim MJ, Park Q, Min HK, Kim HO. Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010. BMC Infect Dis. 2012; 20; 12:160. |
| [37] | WHO. Screening donated blood for transfusion-transmissible infections: recommendations. Geneva. WHO.2009. |
| [38] | Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, et al. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990–2000. CMAJ 2003; 169: 767–773. |
| [39] | Weusten JJ, van Drimmelen HA, Lelie PN. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion. 2002;42(5):537–548. |
| [40] | Dušková D, Darebníček L. Nucleic acid testing of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus 1, 2 in blood donors in the General University Hospital, Prague. Acta Virol. 2014; 58(2):146-51. |
| [41] | Jain R, Aggarwal P, Gupta GN. Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections. Int Sch Res Netw. 2012; 14:1–5. |
| [42] | Kim MJ, Park Q, Min HK, Kim HO. Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010. BMC Infect Dis. 2012; 20; 12:160. |
| [43] | Brant LJ, Reynolds C, Byrne L, Davison KL. Hepatitis B and residual risk of infection in English and Welsh blood donors, 1996 through 2008. Transfusion. 2011; 51(7):1493–1502. |
| [44] | Maresch C, Schluter PJ, Wilson AD, Sleigh A. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil. Transfusion. 2008; 48(2):273–281. |
| [45] | Mustapha SK, JIbrin YB. The prevalence of hepatitis B surface antigenaemia in patients with human immunodeficiency virus (HIV) infection in Gombe, Nigeria. Annals of African Medicine 2004; 3:10-12. |
| [46] | Kitchen AD, Barbara JAJ. Transfusion transmitted infections. In: Murphy MF, Pamphilon DH, editors. Practical Transfusion Medicine. Blackwell Science; Oxford: 2001: 192–210. |
| [47] | Holmberg J. Activities Relating to Global Blood Safety at the Department of Health and Human Services. USA. 2006: 1–5. |
| [48] | Erhabor O. Blood Transfusion Services in sub Saharan Africa. Challenges and Constraints. AuthorHouse Publishing Indiana, USA. ISBN 978-147-72-4872-0 |
| [49] | World Health Organization (WHO) Blood Safety Strategy for the African Region. Brazzaville, World Health Organization, Regional Office for Africa (WHO AFR /RC51/9 Rev.1). 2002. |
| [50] | Busch MP, Glynn SA, Stramer SL, et al. Correlates of hepatitis C virus (HCV) RNA negativity among HCV seropositive blood donors. Transfusion. 2006; 46:469–75. |
| [51] | Mavenyengwa RT1, Mukesi M, Chipare I, Shoombe E. Prevalence of human immunodeficiency virus, syphilis, hepatitis B and C in blood donations in Namibia. BMC Public Health. 2014; 14: 424. |
